measures increase the quality of life and improve the success of treatment,” explains project leader Professor Dr. Tillmann Krüger. The participants continue an already existing drug therapy parallel to the [...] “Patients treated on an outpatient basis are often poorly integrated in society and feel lonely,” says Professor Krüger. “Many of them are also impotent and have little joy in life.” This is where the Take Five [...] more effectively,” explains PhD student and project coordinator Saskia Hamers. The team headed by Professor Krüger wants to find out whether self-chosen measures can improve the well-being of schizophrenic
missing or too weak, the risk of pre-eclampsia increases significantly. A research team led by Professor Dr Frauke von Versen-Höynck, senior physician at the Department of Obstetrics and Gynaecology at [...] causes high blood pressure, often associated with increased protein excretion in the urine," says Professor von Versen-Höynck. In particularly severe cases, liver and kidney dysfunction and seizures can follow [...] placenta, cannot be detected in these pregnant women," says the physician. In the research project, Professor von Versen-Höynck and her team now want to examine and compare placenta and uterine mucosa samples
to repair tissues and organs, such as stem cell-based therapies and gene therapies," describes Professor Dr Nico Lachmann. The researcher at the MHH Clinic for Paediatric Pneumology, Allergology and N [...] innovations, while at the same time providing the tools for successful clinical translation," adds Professor Dr Dr Christine Happle, also a co-spokesperson, from the MHH Department of Paediatric Pneumology [...] vulnerable people from viral and bacterial infections. The spokesperson of the cluster of excellence is Professor Dr. Thomas Schulz, head of the MHH Institute of Virology. More information is available here: www
(HSCs) are massively involved in this tissue remodelling. An international research team led by Professor Dr. Ingmar Mederacke, Managing Senior Physician at the Department of Gastroenterology, Hepatology [...] cell death of hepatocytes and how exactly these molecules are related to fibrosis formation," says Professor Mederacke. The research team found out that certain stored, activated sugar molecules (UDP-glucose [...] thus reduce the development of liver fibrosis. SERVICE: For further information , please contact Professor Dr. Ingmar Mederacke, mederacke.ingmar@mh-hannover.de , phone (0511) 532-6619 The original paper
diseases earlier, treat them or prevent them altogether through preventive action," emphasises Professor Dr. Michael P. Manns, President of Hannover Medical School (MHH), who co-chaired the Liver Commission [...] most liver diseases is possible today thanks to significant achievements in modern medicine," says Professor Manns. The hepatitis B vaccine, for example, is the first vaccine proven to prevent cancer. In addition [...] things, research in the field of liver diseases. SERVICE: For further information , please contact Professor Dr. Michael P. Manns, manns.michael@mh-hannover.de , telephone (0511) 532-6001. The original paper
"This is an outstanding success for the promotion of young scientists at MHH," says MHH President Professor Dr. Michael Manns. "Laura Hinze is an exceptional talent. Actually, she was still too young to take [...] followed. She has been a doctor since December 2020 and has been working as a doctor and scientist in Professor Dr Christian Kratz's paediatric oncology clinic since 1 January 2021. Now she receives the award [...] Laura Hinze, hinze.laura@mh-hannover.de , phone (0511) 532-7880. A video in which MHH President Professor Dr. Michael Manns visits Dr. Laura Hinze's laboratory and talks to her about her research can be
. However, it can be revived with the body's own substance spermidine. A research group led by Professor Dr. Evgeni Ponimaskin from the Institute of Neurophysiology at the Hannover Medical School (MHH) [...] administration affects organs commonly affected by age and the pathway by which this occurs," explains Professor Ponimaskin. The research group of neurophysiologists, nuclear medicine specialists and molecular [...] telomeres in the spermidine-supplemented mice were similar in length to those in young animals," says Professor Ponimaskin. Since the ageing processes in the cells of mice are similar to those in our body cells
– this is the ambitious goal of scientists at Hannover Medical School (MHH). With this in mind, Professor Dr. Nico Lachmann and Dr. Robert Zweigerdt have initiated a research collaboration and license agreement [...] study. So far, there has been no clinical application of iPS cell progenies in Germany," explains Professor Lachmann. Macrophages as a therapeutic agent for bacterial lung infections In pre-clinical proo [...] am very pleased that we can now advance this idea towards real therapies," says Dr. Zweigerdt. Professor Lachmann holds a professorship funded by the Cluster of Excellence RESIST and conducts research
practice are supported by the co-directorship of a clinical director, Professor Axel Haverich, and a research director, Professor Ulrich Martin. The LEBAO as a basic research area of the Clinic for Cardiac [...] The Leibniz Research Laboratories for Biotechnology and Artificial Organs (LEBAO) were founded by Professor Axel Haverich at the Hannover Medical School (MHH) in 1996 finaced through the prestigious Leibniz
Biotechnology and Artificial Organs (LEBAO) at the Hannover Medical School (MHH) and LEBAO director Professor Dr. Ulrich Martin, now want to develop a new therapy in which damaged tissue areas can be repaired [...] tissue and improve organ function in animal models as part of the iCARE project coordinated by Professor Martin. In the new research project HEAL, the strategies for producing and administering the iPS [...] gene into the iPS cells that can be activated if the applied cells degenerate in the body," says Professor Martin. "In the end, we want to produce safe cell products that can also be produced on a large